Profile data is unavailable for this security.
About the company
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
- Revenue in USD (TTM)8.68m
- Net income in USD-11.39m
- Incorporated2008
- Employees31.00
- LocationReShape Lifesciences Inc1001 CALLE AMANECERSAN CLEMENTE 92673United StatesUSA
- Phone+1 (949) 429-6680
- Fax+1 (302) 636-5454
- Websitehttps://www.reshapelifesciences.com/obalon/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innovative Eyewear Inc | 1.15m | -6.66m | 2.64m | 11.00 | -- | 0.4634 | -- | 2.29 | -0.6442 | -0.6442 | 0.1098 | 0.4303 | 0.2113 | 4.05 | 11.33 | 104,770.90 | -122.17 | -- | -137.62 | -- | -10.35 | -- | -578.18 | -- | 8.14 | -2,255.11 | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
| InnerScope Hearing Technologies, Inc. | 334.45k | -7.15m | 2.67m | 24.00 | -- | -- | -- | 8.00 | -0.0153 | -0.0153 | 0.0002 | -0.0028 | 0.0955 | 3.93 | 1.71 | -- | -204.11 | -27.82 | -- | -94.53 | 17.79 | 58.17 | -2,138.50 | -42.13 | 0.0022 | -0.4232 | -- | -- | -- | 100.59 | -- | -- | 233.50 | -- |
| Vycor Medical Inc | 1.46m | -387.45k | 2.74m | 8.00 | -- | -- | -- | 1.88 | -0.0122 | -0.0124 | 0.0432 | -0.1019 | 1.58 | 0.6002 | 7.86 | 182,575.00 | -6.81 | -47.86 | -- | -- | 90.08 | 89.60 | -4.32 | -35.42 | 0.0859 | 0.389 | -- | -- | 19.43 | -0.6542 | 46.49 | -- | -31.77 | -- |
| Invo Bioscience Inc | 3.02m | -8.03m | 2.74m | 25.00 | -- | -- | -- | 0.9081 | -9.13 | -9.13 | 2.57 | 0.3582 | 0.2417 | 6.73 | 27.75 | 120,822.80 | -64.30 | -94.63 | -120.25 | -151.45 | 41.20 | 74.91 | -266.00 | -343.11 | 0.1211 | -6.86 | 0.7558 | -- | 267.38 | 43.62 | 26.24 | -- | 87.09 | -- |
| Tenon Medical Inc | 2.93m | -15.58m | 2.81m | 21.00 | -- | 2.52 | -- | 0.961 | -10.28 | -10.28 | 1.62 | 0.2992 | 0.3359 | 3.48 | 7.85 | 139,428.60 | -178.74 | -- | -264.89 | -- | 42.38 | -- | -532.14 | -- | 1.06 | -- | 0.6012 | -- | 323.73 | -- | 17.63 | -- | -- | -- |
| Helius Medical Technologies Inc | -100.00bn | -100.00bn | 3.54m | 26.00 | -- | 1.21 | -- | -- | -- | -- | -- | 3.29 | -- | -- | -- | -- | -- | -98.37 | -- | -143.57 | -- | 37.27 | -- | -1,580.66 | 3.72 | -- | -- | -- | -18.17 | 6.14 | 37.11 | -- | -- | -- |
| Aethlon Medical, Inc. | 574.25k | -12.26m | 3.62m | 15.00 | -- | 0.4708 | -- | 6.30 | -5.03 | -5.03 | 0.2362 | 2.93 | 0.0369 | -- | -- | 38,283.33 | -78.62 | -75.30 | -92.02 | -84.98 | -- | -- | -2,133.17 | -1,783.78 | -- | -- | 0.00 | -- | 95.21 | 30.86 | -15.55 | -- | 106.99 | -- |
| ReShape Lifesciences Inc | 8.68m | -11.39m | 3.89m | 31.00 | -- | 0.5844 | -- | 0.4487 | -3.77 | -3.77 | 1.46 | 0.2841 | 0.796 | 0.8515 | 4.52 | 279,935.50 | -104.44 | -136.06 | -215.93 | -194.32 | 63.93 | 56.30 | -131.22 | -408.36 | 1.74 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
| Catheter Precision Inc | 442.00k | -71.37m | 4.16m | 14.00 | -- | 0.182 | -- | 9.41 | -25.32 | -25.32 | 0.0806 | 3.02 | 0.0186 | 1.36 | 6.45 | 31,571.43 | -296.70 | -- | -376.14 | -- | 93.21 | -- | -15,966.52 | -- | 1.67 | -- | 0.0086 | -- | 3,057.14 | -- | -165.67 | -- | -- | -- |
| Venus Concept Inc | 76.35m | -37.25m | 4.19m | 304.00 | -- | -- | -- | 0.0549 | -6.86 | -6.86 | 14.05 | -2.54 | 0.6972 | 1.03 | 2.30 | 251,164.50 | -33.83 | -32.71 | -50.39 | -44.01 | 68.32 | 68.16 | -48.52 | -48.50 | 1.39 | -3.93 | 1.22 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
| Sharps Technology Inc | 0.00 | -9.84m | 4.20m | 3.00 | -- | 0.5157 | -- | -- | -0.7645 | -0.7645 | 0.00 | 0.5195 | 0.00 | -- | -- | -- | -83.30 | -- | -109.78 | -- | -- | -- | -- | -- | 0.8474 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
| Encision Inc | 6.87m | -448.00k | 4.32m | 31.00 | -- | 1.97 | -- | 0.6293 | -0.0381 | -0.0381 | 0.5835 | 0.1863 | 1.64 | 1.96 | 7.84 | 221,520.00 | -10.69 | -1.07 | -14.05 | -1.46 | 50.54 | 52.27 | -6.52 | -0.613 | 1.08 | -6.22 | 0.1123 | -- | -4.17 | -3.44 | -393.90 | -- | 12.89 | -- |
| Acutus Medical Inc | 7.16m | -11.92m | 4.46m | 233.00 | -- | -- | -- | 0.6222 | -0.4097 | -0.417 | 0.2467 | -0.0308 | 0.0765 | 1.17 | 0.4417 | 30,746.78 | -12.72 | -46.76 | -16.05 | -56.88 | -43.79 | -89.12 | -166.40 | -773.49 | 2.22 | -6.78 | 1.03 | -- | 136.36 | 27.03 | -141.35 | -- | -35.99 | -- |
| BIOLASE Inc | 49.16m | -37.62m | 4.93m | 157.00 | -- | -- | -- | 0.1003 | -37.97 | -37.97 | 38.54 | 0.5726 | 1.34 | 2.38 | 8.68 | 313,146.50 | -56.30 | -49.28 | -115.21 | -85.80 | 34.02 | 35.27 | -41.97 | -50.72 | 0.683 | -6.61 | 0.8778 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
| Bioelectronics Corp | 1.61m | -289.82k | 4.94m | 9.00 | -- | -- | -- | 3.07 | -0.00002 | -0.00002 | 0.00007 | -0.0006 | 6.32 | 9.20 | 14.53 | -- | -113.86 | -383.59 | -- | -- | 49.43 | 51.48 | -18.01 | -143.48 | 0.0099 | -0.4909 | -- | -- | 94.01 | -5.09 | 75.01 | -- | -- | -- |
| Pressure Biosciences Inc | 2.27m | -29.56m | 5.18m | 15.00 | -- | -- | -- | 2.28 | -1.70 | -1.70 | 0.1299 | -1.22 | 1.02 | 2.28 | 9.17 | 151,505.30 | -1,074.63 | -643.54 | -- | -- | 6.89 | 34.75 | -1,050.30 | -798.21 | 0.0185 | -0.4182 | -- | -- | -13.64 | -5.05 | 21.52 | -- | -34.47 | -- |
Data as of May 01 2024. Currency figures normalised to ReShape Lifesciences Inc's reporting currency: US Dollar USD
1.91%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Two Sigma Securities LLCas of 31 Dec 2023 | 75.58k | 0.32% |
| Virtu Americas LLCas of 31 Dec 2023 | 73.53k | 0.31% |
| Citadel Securities LLCas of 31 Dec 2023 | 72.87k | 0.31% |
| G1 Execution Services LLCas of 31 Dec 2023 | 59.04k | 0.25% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 49.87k | 0.21% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 34.06k | 0.15% |
| Gesalcal� SA SGIICas of 31 Dec 2023 | 26.01k | 0.11% |
| Millennium Management LLCas of 31 Dec 2023 | 21.18k | 0.09% |
| Geode Capital Management LLCas of 31 Dec 2023 | 18.35k | 0.08% |
| Tower Research Capital LLCas of 31 Dec 2023 | 17.07k | 0.07% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
